Fibrates

Results: 99



#Item
21Module 8 Lipid Management in Diabetic Patients

Module 8 Lipid Management in Diabetic Patients

Add to Reading List

Source URL: www.pco.gov.hk

Language: English - Date: 2014-06-30 07:36:31
22Module 8 Lipid Management in Diabetic Patients

Module 8 Lipid Management in Diabetic Patients

Add to Reading List

Source URL: www.pco.gov.hk

Language: English - Date: 2014-06-30 07:36:31
23HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VYTORIN safely and effectively. See full prescribing information for VYTORIN. ®

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VYTORIN safely and effectively. See full prescribing information for VYTORIN. ®

Add to Reading List

Source URL: www.merck.com

Language: English - Date: 2015-02-06 14:24:53
24Proline- and acidic amino acid-rich basic leucine zipper proteins modulate peroxisome proliferatoractivated receptor α (PPARα) activity Frédéric Gachona,b,1, Nicolas Leuenbergerc,2, Thierry Claudeld, Pascal Gosa, Cé

Proline- and acidic amino acid-rich basic leucine zipper proteins modulate peroxisome proliferatoractivated receptor α (PPARα) activity Frédéric Gachona,b,1, Nicolas Leuenbergerc,2, Thierry Claudeld, Pascal Gosa, Cé

Add to Reading List

Source URL: www.molbio.unige.ch

Language: English - Date: 2011-06-10 04:05:34
25doi:[removed]j.jacl[removed]

doi:[removed]j.jacl[removed]

Add to Reading List

Source URL: triglyceridespanel.ajconline.org

Language: English - Date: 2014-05-14 15:37:54
26Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)

Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)

Add to Reading List

Source URL: triglyceridespanel.ajconline.org

Language: English - Date: 2014-05-14 15:37:55
27Volume 26 (1), 2006 Editors Barbara Cadario, B.Sc.(Honours), B.Sc.Phm., M.Sc. Karen L.A. Wlock, B.Sc.(Pharm.)  Contents

Volume 26 (1), 2006 Editors Barbara Cadario, B.Sc.(Honours), B.Sc.Phm., M.Sc. Karen L.A. Wlock, B.Sc.(Pharm.) Contents

Add to Reading List

Source URL: dpic.org

Language: English - Date: 2014-11-10 15:46:28
28Volume 27 (1), 2007 Editors Barbara Cadario, B.Sc.(Hon), B.Sc.Phm., M.Sc. Karen L.A. Wlock, B.Sc.(Pharm.)  Contents

Volume 27 (1), 2007 Editors Barbara Cadario, B.Sc.(Hon), B.Sc.Phm., M.Sc. Karen L.A. Wlock, B.Sc.(Pharm.) Contents

Add to Reading List

Source URL: dpic.org

Language: English - Date: 2014-11-10 15:46:27
29LOPID  (Gemfibrozil Tablets, USP) DESCRIPTION LOPID® (gemfibrozil tablets, USP) is a lipid regulating agent. It is available as tablets for

LOPID (Gemfibrozil Tablets, USP) DESCRIPTION LOPID® (gemfibrozil tablets, USP) is a lipid regulating agent. It is available as tablets for

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-11-06 11:32:51
30Lipofen® (fenofibrate capsules USP) for oral use 50 mg and 150 mg January 2013 This document contains the labeling text which may be accessed on the NIH DailyMed page

Lipofen® (fenofibrate capsules USP) for oral use 50 mg and 150 mg January 2013 This document contains the labeling text which may be accessed on the NIH DailyMed page

Add to Reading List

Source URL: www.lipofenrx.com

Language: English - Date: 2014-07-21 12:21:39